"Top end of revenue growth guidance." Should easily push through the $1 barrier and push on to $1.20+
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025